Oncology PracticeFDA approves encorafenib/binimetinib for advanced melanoma with BRAF mutationsJune 27, 2018Melanoma
Oncology PracticeRegistry data provide evidence that Mohs surgery remains underutilizedJune 22, 2018Nonmelanoma Skin CancerMelanoma
Oncology PracticeIMPACT study: Matched targeted therapy improves survival in advanced cancerJune 4, 2018MelanomaGastroenterologyBreast CancerLung CancerGastrointestinal Cancer
Oncology PracticePediatric cancers are on the riseMay 17, 2018PediatricsAggressive LymphomasALLMelanoma
Oncology PracticeIs cancer immunotherapy more effective in men than women?May 16, 2018Immuno-oncologyImmunotherapyGenitourinary CancerGastroenterologyRenal Cell CarcinomaMelanomaLung Cancer
Oncology PracticeCheckpoint inhibitors get to patients quicklyMay 10, 2018Renal Cell CarcinomaImmuno-oncologyLung CancerMelanoma
Oncology PracticeWorld Trade Center responders face greater cancer burden, including greater risk of multiple myelomaApril 26, 2018Leukemia, Myelodysplasia, TransplantationMultiple MyelomaPatient & Survivor CarePreventive CareGenitourinary CancerMelanoma
Oncology PracticeEarly results favorable for combo TLR9 agonist + pembro in advanced melanomaApril 23, 2018MelanomaImmuno-oncology
Oncology PracticeKEYNOTE-054: Adjuvant pembrolizumab beat placebo in high-risk resected melanomaApril 16, 2018Immuno-oncologyMelanoma
Oncology PracticeSurgery after immunotherapy effective in advanced melanomaApril 10, 2018MelanomaImmuno-oncology
